Micro-invasive Pulmonary Devices
Pulmonary Diseases (e.g., Lung Cancer, COPD)
Pre-clinicalActive
Key Facts
About Sanovas
Sanovas is a private, pre-revenue medical technology holding company founded in 2008, specializing in micro-invasive devices and targeted drug delivery for pulmonary and other conditions. The company operates by developing and spinning out specific technology platforms into separate ventures. Key challenges include its pre-commercial status, ongoing legal matters referenced on its website, and the regulatory pathway required for its investigational devices. Its strategy hinges on creating novel, minimally invasive platforms to address unmet needs in interventional pulmonology and beyond.
View full company profile